Go to Page # Page of 20
loading

Takeda 143rd Ordinary General Meeting of Shareholders

 Takeda Pharmaceutical Company Limited
  22nd-Aug-2019
Description: Takeda is a Pharmaceutical Company. Here present the Takeda's 143rd Ordinary General Meeting of Shareholders with consolidated financial results for FY2018 and guidance for FY2019.
Views: 1201
Domain: Business
Category: Companies
weSRCH App on Apple
Contents:
143rd Ordinary General Meeting of Shareholders
Consolidated Financial Results for FY2018 and Guidance for FY2019
June 27th, 2019

IMPORTANT NOTICE
For the purposes of this notice, “presentation” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda&rd ... See more

Recent Presentations

Damien Browne
20 September, 2019
...
19 September, 2019

HP Company Overview

Here present HP company overview with financial analysis. Mainly HP holding the strong market position, improving efficiency post-split and leveling industry outlook.

UC Santa Cruz
18 September, 2019